Krux AI
Company brain · pharma
Workspace
System
Leadership
JD
John Doe
Strategy & Finance
Pipeline

Inbound RFPs.

+ Ingest new RFPBulk proposals →
Connecting…
Every RFP your BD team receives, newest first. Click into one to see the parsed requirements, hard constraints, evaluation criteria, and generate cited draft responses grounded in your knowledge base.
Ready to draft
1
Parsing now
0
Total ingested
1
Velora Therapeutics, Inc.ready
velora-vlr2876-rfp.pdf
Velora Therapeutics seeks a CDMO partner to develop a scalable cGMP-ready process for VLR-2876, a covalent KRAS-G12D inhibitor, and manufacture 25 kg of tosylate salt (Form I anhydrous) by September 2026 supporting Phase…
→
small molecule NCE· 25 kg· Phase 1b/2· due Jun 26, 2026· 0/30 drafted· 88d ago